The basic residue cluster 55KKWVR59 in CCL5 is required for in vivo biologic function

Molecular Immunology

Volumn 46, Issue 13, 2009, Pages 2533-2538

  Segerer, Stephan ^a,b   Johnson, Zoë ^c   Rek, Angelika ^d   Baltus, Thomas ^e   von Hundelshausen, Philipp ^e   Kungl, Andreas J ^d   Proudfoot, Amanda E I ^c   Weber, Christian ^e   Nelson, Peter J ^f  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c SERONO PHARMACEUTICAL RES INSTITUTE   (Switzerland)

^d UNIVERSITY OF GRAZ   (Austria)

^e UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^f LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

CCL5; Chemokine presentation; Chemokines; Glycosaminoglycans; RANTES

Indexed keywords

AMINO ACID; GLYCOSAMINOGLYCAN; RANTES;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ADHESION; CELL SURFACE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; EX VIVO STUDY; EXTRACELLULAR MATRIX; FEMALE; GENE CLUSTER; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MONOCYTE; MOUSE; NONHUMAN; PERITONEAL CAVITY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN STRUCTURE; T LYMPHOCYTE; WILD TYPE;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ANIMALS; CELL ADHESION; CELL LINE; CELL MOVEMENT; CHEMOKINE CCL5; ENDOTHELIAL CELLS; FEMALE; FLOW CYTOMETRY; GLYCOSAMINOGLYCANS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; LEUKOCYTES; MICE; MICE, INBRED BALB C; MUTATION; OLIGOSACCHARIDES; PROTEIN BINDING;

EID: 67650474631     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2009.05.015     Document Type: Article

References (38)

1. Baggiolini M., Dewald B., and Moser B. Human chemokines: an update. Annu. Rev. Immunol. 15 (1997) 675-705
2. Baltus T., Weber K.S., Johnson Z., et al. Oligomerization of RANTES is required for CCR1-mediated arrest but not CCR5-mediated transmigration of leukocytes on inflamed endothelium. Blood 102 (2003) 1985-1988
3. Brandner B., Rek A., Diedrichs-Möhring M., Wildner G., and Kungl A.J. Engineering the glycosaminoglycan-binding affinity, kinetics and oligomerization behavior of RANTES: a tool for generating chemokine-based glycosaminoglycan antagonists. Protein Eng Des Sel. 22 (2009) 367-373
4. Cox J.H., Dean R.A., Roberts C.R., et al. Matrix metalloproteinase processing of CXCL11/I-TAC results in loss of chemoattractant activity and altered glycosaminoglycan binding. J. Biol. Chem. 283 (2008) 19389-19399
5. de Paz J.L., Moseman E.A., Noti C., et al. Profiling heparin-chemokine interactions using synthetic tools. ACS Chem. Biol. 2 (2007) 735-744
6. Goger B., Halden Y., Rek A., et al. Different affinities of glycosaminoglycan oligosaccharides for monomeric and dimeric interleukin-8: a model for chemokine regulation at inflammatory sites. Biochemistry 41 (2002) 1640-1646
7. Handel T.M., Johnson Z., Crown S.E., et al. Regulation of protein function by glycosaminoglycans-as exemplified by chemokines. Annu. Rev. Biochem. 74 (2005) 385-410
8. Hoogewerf A.J., Kuschert G.S., Proudfoot A.E., et al. Glycosaminoglycans mediate cell surface oligomerization of chemokines. Biochemistry 36 (1997) 13570-13578
9. Hub E., and Rot A. Binding of RANTES, MCP-1, MCP-3, and MIP-1alpha to cells in human skin. Am. J. Pathol. 152 (1998) 749-757
10. Johnson Z., Kosco-Vilbois M.H., Herren S., et al. Interference with heparin binding and oligomerization creates a novel anti-inflammatory strategy targeting the chemokine system. J. Immunol. 173 (2004) 5776-5785
11. Koopmann W., Ediriwickrema C., and Krangel M.S. Structure and function of the glycosaminoglycan binding site of chemokine macrophage-inflammatory protein-1 beta. J. Immunol. 163 (1999) 2120-2127
12. Kuschert G.S., Coulin F., Power C.A., et al. Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses. Biochemistry 38 (1999) 12959-12968
13. Laguri C., Arenzana-Seisdedos F., and Lortat-Jacob H. Relationships between glycosaminoglycan and receptor binding sites in chemokines-the CXCL12 example. Carbohydr. Res. 343 (2008) 2018-2023
14. Laguri C., Sadir R., Rueda P., et al. The novel CXCL12gamma isoform encodes an unstructured cationic domain which regulates bioactivity and interaction with both glycosaminoglycans and CXCR4. PLoS ONE 2 (2007) e1110
15. Ley K. Arrest chemokines. Microcirculation 10 (2003) 289-295
16. Ley K., Laudanna C., Cybulsky M.I., et al. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat. Rev. Immunol. 7 (2007) 678-689
17. Luster A.D. The role of chemokines in linking innate and adaptive immunity. Curr. Opin. Immunol. 14 (2002) 129-135
18. Martin L., Blanpain C., Garnier P., et al. Structural and functional analysis of the RANTES-glycosaminoglycans interactions. Biochemistry 40 (2001) 6303-6318
19. Murphy P.M., Baggiolini M., Charo I.F., et al. International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol. Rev. 52 (2000) 145-176
20. Parish C.R. The role of heparan sulphate in inflammation. Nat. Rev. Immunol. 6 (2006) 633-643
21. Proudfoot A.E. The biological relevance of chemokine-proteoglycan interactions. Biochem. Soc. Trans. 34 (2006) 422-426
22. Proudfoot A.E., Fritchley S., Borlat F., et al. The BBXB motif of RANTES is the principal site for heparin binding and controls receptor selectivity. J. Biol. Chem. 276 (2001) 10620-10626
23. Proudfoot A.E., Handel T.M., Johnson Z., et al. Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 1885-1890
24. Rot A. Binding of neutrophil attractant/activation protein-1 (interleukin 8) to resident dermal cells. Cytokine 4 (1992) 347-352
25. Rot A. Endothelial cell binding of NAP-1/IL-8: role in neutrophil emigration. Immunol. Today 13 (1992) 291-294
26. Rot A., Hub E., Middleton J., et al. Some aspects of IL-8 pathophysiology. III: chemokine interaction with endothelial cells. J. Leukoc. Biol. 59 (1996) 39-44
27. Sadir R., Baleux F., Grosdidier A., et al. Characterization of the stromal cell-derived factor-1alpha-heparin complex. J. Biol. Chem. 276 (2001) 8288-8296
28. Sandhoff R., Grieshaber H., Djafarzadeh R., et al. Chemokines bind to sulfatides as revealed by surface plasmon resonance. Biochim. Biophys. Acta 1687 (2005) 52-63
29. Schenauer M.R., Yu Y., Sweeney M.D., et al. CCR2 chemokines bind selectively to acetylated heparan sulfate octasaccharides. J. Biol. Chem. 282 (2007) 25182-25188
30. Segerer S., Djafarzadeh R., Grone H.J., et al. Selective binding and presentation of CCL5 by discrete tissue microenvironments during renal inflammation. J. Am. Soc. Nephrol. 18 (2007) 1835-1844
31. Simon S.I., and Green C.E. Molecular mechanics and dynamics of leukocyte recruitment during inflammation. Annu. Rev. Biomed. Eng. 7 (2005) 151-185
32. Spillmann D., Witt D., and Lindahl U. Defining the interleukin-8-binding domain of heparan sulfate. J. Biol. Chem. 273 (1998) 15487-15493
33. Springer T.A. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76 (1994) 301-314
34. Tanaka Y., Adams D.H., Hubscher S., et al. T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1 beta. Nature 361 (1993) 79-82
35. von Hundelshausen P., Weber K.S., Huo Y., et al. RANTES deposition by platelets triggers monocyte arrest on inflamed and atherosclerotic endothelium. Circulation 103 (2001) 1772-1777
36. Weber C., Weber K.S., Klier C., et al. Specialized roles of the chemokine receptors CCR1 and CCR5 in the recruitment of monocytes and T(H)1-like/CD45RO(+) T cells. Blood 97 (2001) 1144-1146
37. Weber K.S., Klickstein L.B., and Weber C. Specific activation of leukocyte beta2 integrins lymphocyte function-associated antigen-1 and Mac-1 by chemokines mediated by distinct pathways via the alpha subunit cytoplasmic domains. Mol. Biol. Cell 10 (1999) 861-873
38. Wiedermann C.J., Kowald E., Reinisch N., et al. Monocyte haptotaxis induced by the RANTES chemokine. Curr. Biol. 3 (1993) 735-739